Invesco
CTXR icon

Invesco’s Citius Pharmaceuticals CTXR Stock Holding History

Invesco’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,254
Closed -$50.6K – 3896
2024
Q1 		$50.6K Sell
2,254
-78
-3% -$1.42K ﹤0.01% 3801
2023
Q4 		$44.1K Buy
2,332
+370
+19% +$7.02K ﹤0.01% 3756
2023
Q3 		$33.6K Hold
1,962
– – ﹤0.01% 3824
2023
Q2 		$58.9K Buy
+1,962
New +$64.6K ﹤0.01% 3805
2022
Q2 		– Sell
-1,308
Closed -$59K – 4061
2022
Q1 		$59K Buy
1,308
+28
+2% +$1.11K ﹤0.01% 3915
2021
Q4 		$49K Sell
1,280
-903
-41% -$41K ﹤0.01% 3982
2021
Q3 		$110K Buy
2,183
+435
+25% +$21.8K ﹤0.01% 3922
2021
Q2 		$152K Buy
+1,748
New +$105K ﹤0.01% 3836

Other funds holding CTXR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco's CTXR Position: Q2 2024 in Review

Invesco sold out of Citius Pharmaceuticals (CTXR) in Q2 2024, closing a stake of 2,254 shares — an estimated $50.6K sold.

Invesco first reported a position in CTXR in Q2 2021 and held it in 8 quarters. The position peaked at $152K in Q2 2021. 72 funds tracked by Wall St. Rank hold CTXR as of Q2 2024.

  • Invesco reported no remaining Citius Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Invesco sold 2,254 Citius Pharmaceuticals shares in Q2 2024, an estimated $50.6K.
  • Invesco first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • Invesco's Citius Pharmaceuticals position peaked at $152K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.